Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide

Alpha-Globin Gene Deletion or Duplication

Test code(s) 16124(X), 16125X (NY)

  • Consider eliminating iron deficiency anemia as a possibility.
  • In the absence of iron deficiency, there may be other genetic causes for abnormal RBC indices and HPLC results. Point mutations in the alpha 1 and alpha 2 genes may be present. Alpha-Globin Gene Sequencing (test code 16116X [16117X for NY]) can detect point mutations in these genes. Please call 1.866.GENE.INFO (1.866.436.3463) to discuss the case, the patient’s indices, and additional testing options.

Both parents must be carriers of a thalassemia mutation for a pregnancy to be at risk. For example, if one parent carries an alpha-globin triplication (5 alpha gene copies) and the other parent carries a beta zero mutation, the fetus could be at risk for beta-thalassemia intermedia. The partner should be screened to determine his/her hemoglobinopathy carrier status (Hemoglobinopathy Evaluation; test code 35489X). Molecular genetic testing may also be appropriate for the partner. Please call 1.866.GENE.INFO (1.866.436.3463) to discuss the case with a genetic counselor.

For family planning purposes, it is important to determine which gene deletions are present and to distinguish whether the deletions are in cis or in trans. The Alpha-Globin Common Mutation Analysis test (test code 11175 [11174 for NY]) can detect the seven most common deletions and identify whether the deletions are in cis or in trans. This will help assess whether a fetus could be at risk for alpha-thalassemia major or hemoglobin H disease, if the partner is also an alpha-thalassemia carrier.

This FAQ is provided for informational purposes only and is not intended as medical advice. A clinician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

Document: FAQS.29 Revision: 1